Cargando…

Single-dose trastuzumab monotherapy achieved pathological complete response (pCR) in a patient with HER2-positive breast cancer: a case report

BACKGROUND: With advances in breast cancer treatment, the importance of de-escalation therapy to reduce harm during the treatment of elderly patients has attracted attention in recent years. Certain patient populations are expected to have a superior response to anti-HER2 drugs, particularly those w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Isogai, Ayaka, Kotani, Haruru, Sawaki, Masataka, Hattori, Masaya, Yoshimura, Akiyo, Kataoka, Ayumi, Nozawa, Kazuki, Ozaki, Yuri, Endo, Yuka, Nakakami, Akira, Komaki, Rie, Iwata, Hiroji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284776/ https://www.ncbi.nlm.nih.gov/pubmed/37341815 http://dx.doi.org/10.1186/s40792-023-01661-4

Ejemplares similares

Time to Chemotherapy for Patients With Estrogen Receptor-Positive Breast Cancer and Cyclin-Dependent Kinase 4 and 6 Inhibitor Use
por: Endo, Yuka, et al.
Publicado: (2022)

Evaluation of the Role of Axillary Lymph Node Fine-Needle Aspiration Cytology in Early Breast Cancer With or Without Neoadjuvant Chemotherapy
por: Takatsuka, Daiki, et al.
Publicado: (2023)

Mechanisms and anatomical risk factors of pneumothorax after Bevacizumab use: A case report
por: Ozaki, Yuri, et al.
Publicado: (2020)

The significance of biopsy scar excision at the time of skin- or nipple-sparing mastectomy with immediate breast reconstruction
por: Ozaki, Yuri, et al.
Publicado: (2021)

A case of radiation-associated angiosarcoma after breast cancer
por: Horisawa, Nanae, et al.
Publicado: (2018)

Amyloid tumor of the breast
por: Mori, Makiko, et al.
Publicado: (2019)

A case of giant cell tumor of the breast, clinically suspected as malignant breast tumor
por: Terada, Mitsuo, et al.
Publicado: (2019)

Compression therapy using surgical gloves does not prevent paclitaxel-induced peripheral neuropathy: results from a double-blind phase 2 trial
por: Kotani, Haruru, et al.
Publicado: (2021)

Circulating tumor cells detection in tumor draining vein of breast cancer patients
por: Hattori, Masaya, et al.
Publicado: (2019)

Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma
por: Adachi, Yayoi, et al.
Publicado: (2016)

Bone Scan Index predicts skeletal-related events in patients with metastatic breast cancer
por: Idota, Ai, et al.
Publicado: (2016)

Impact of intrinsic subtype on predicting axillary lymph node metastasis in breast cancer
por: SAWAKI, MASATAKA, et al.
Publicado: (2014)

Trastuzumab emtansine in the treatment of HER2-positive metastatic breast cancer in Japanese patients
por: Sawaki, Masataka
Publicado: (2014)

Real-world treatment patterns of subsequent therapy after palbociclib in patients with advanced breast cancer in Japan
por: Sawaki, Masataka, et al.
Publicado: (2023)

Functions of Breast Cancer Predisposition Genes: Implications for Clinical Management
por: Yoshimura, Akiyo, et al.
Publicado: (2022)

Phase 1 trial of entinostat as monotherapy and combined with exemestane in Japanese patients with hormone receptor-positive advanced breast cancer
por: Masuda, Norikazu, et al.
Publicado: (2021)

Erythrodysesthesia: An Unusual Complication With Trastuzumab Monotherapy
por: Fontenot, Andee L, et al.
Publicado: (2021)

Cost-Effectiveness of Trastuzumab With or Without Chemotherapy as Adjuvant Therapy in HER2-Positive Elderly Breast Cancer Patients: A Randomized, Open-Label Clinical Trial, the RESPECT Trial
por: Takumoto, Yuki, et al.
Publicado: (2022)

Practice management for elderly patients with breast cancer; Findings from a survey by the Japan Breast Cancer Study Group
por: Sawaki, Masataka, et al.
Publicado: (2018)

Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study
por: Hattori, Masaya, et al.
Publicado: (2017)

Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study
por: Hattori, Masaya, et al.
Publicado: (2017)

Pooled analysis of drug-related interstitial lung disease and/or pneumonitis in nine trastuzumab deruxtecan monotherapy studies
por: Powell, C.A., et al.
Publicado: (2022)

Trastuzumab Associated With Recurrent Severe Thrombocytopenia and Successful Use of Pertuzumab Monotherapy
por: Huff, Mallorie L, et al.
Publicado: (2022)

Recent Improvement in the Long-term Survival of Breast Cancer Patients by Age and Stage in Japan
por: Yoshimura, Akiyo, et al.
Publicado: (2018)

Rainbow of KIBOU (ROK) study: a Breast Cancer Survivor Cohort in Japan
por: Mizota, Yuri, et al.
Publicado: (2017)

Efficacy and safety of talazoparib in Japanese patients with germline BRCA-mutated locally advanced or metastatic breast cancer: results of the phase 1 dose-expansion study
por: Kotani, Haruru, et al.
Publicado: (2022)

Dramatic Clinical Response of Relapsed Metastatic Extramammary Paget's Disease to Trastuzumab Monotherapy
por: Wakabayashi, S., et al.
Publicado: (2012)

Trastuzumab monotherapy for bone marrow metastasis of breast cancer: A case report
por: XU, LONG, et al.
Publicado: (2014)

Adjuvant trastuzumab without chemotherapy for treating early HER2-positive breast cancer in older patients: A propensity score-adjusted analysis of a prospective cohort study
por: Sawaki, Masataka, et al.
Publicado: (2022)

Current Status of Advance Care Planning and End‐of‐life Communication for Patients with Advanced and Metastatic Breast Cancer
por: Sagara, Yasuaki, et al.
Publicado: (2021)

Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational Study
por: Yamashiro, Hiroyasu, et al.
Publicado: (2018)

Correction to: The Japanese Breast Cancer Society clinical practice guidelines for surgical treatment of breast cancer, 2018 edition
por: Inokuchi, Masafumi, et al.
Publicado: (2021)

The Japanese Breast Cancer Society clinical practice guidelines for surgical treatment of breast cancer, 2018 edition
por: Inokuchi, Masafumi, et al.
Publicado: (2019)

Trastuzumab deruxtecan for the treatment of patients with HER2-positive gastric cancer
por: Kotani, Daisuke, et al.
Publicado: (2021)

Efficient Multiple Genome Modifications Induced by the crRNAs, tracrRNA and Cas9 Protein Complex in Zebrafish
por: Kotani, Hirohito, et al.
Publicado: (2015)

High-temperature corrosion behavior of high-temperature and high-pressure cavitation processed Cr–Mo steel surface
por: Ijiri, Masataka, et al.
Publicado: (2020)

An experience with ibrutinib monotherapy for Richter’s syndrome isolated in the central nervous system
por: Nato, Yuma, et al.
Publicado: (2022)

Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data
por: Schmid, Sabine, et al.
Publicado: (2019)

Combination efficacy of pertuzumab and trastuzumab for trastuzumab emtansine-resistant cells exhibiting attenuated lysosomal trafficking or efflux pumps upregulation
por: Yamashita-Kashima, Yoriko, et al.
Publicado: (2020)

Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study
por: Sawaki, Akira, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_cjj55vq9r9kijqido0i00q0qt8